Peptable

Comparison

PT-141 vs Sermorelin

Function

While PT-141 is FDA-approved for treatment of hypoactive sexual desire disorder in premenopausal women and is studied for sexual dysfunction in other populations, increasing sexual desire via CNS melanocortin pathways42101, Sermorelin is used as a diagnostic agent for assessing GH secretory capacity and as a research tool or off-label therapy to increase endogenous GH in GH-deficient or age-related contexts1727.

Mechanism

While PT-141 works as the synthetic melanocortin receptor agonist bremelanotide, an analog of α-MSH that activates central MC3R and MC4R to modulate neuronal circuits governing sexual desire and arousal3242101, Sermorelin is a synthetic 29-amino-acid peptide identical to the 1–29 N-terminal fragment of human GHRH that stimulates GH synthesis and secretion by binding pituitary GHRH receptors1727120.

Receptor

PT-141

Melanocortin receptors, with highest functional relevance at MC4R and MC3R; also binds MC1R and MC5R3242

Sermorelin

Growth hormone–releasing hormone receptor (GHRHR) on pituitary somatotrophs94103120

Organism or Origin

PT-141

Synthetic analog of human α-MSH derived from POMC428190

Sermorelin

Synthetic peptide corresponding to human hypothalamic GHRH(1–29) 17120

Gene

PT-141

POMC

Sermorelin

GHRH

Summary

PT-141 and Sermorelin are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: PT-141 is more often discussed in the realm of Reproductive health, whereas Sermorelin is more often associated with the realm of Metabolic and endocrine and Aging and longevity. They also influence different molecular systems, with PT-141 tracking more closely to GPCR receptor while Sermorelin centers more on Growth hormone axis. Both are synthetic in origin. PT-141 takes the form of a cyclic peptide, whereas Sermorelin is closer to a linear peptide, PT-141 carries acetylation features, while Sermorelin instead reflects amidation changes; while their sequence patterns also diverge, with PT-141 showing protein-mimetic sequence features and Sermorelin showing alpha-helical domain features.

Related articles

No related articles are linked to these peptides yet.

Sources

32PT-141 (Bremelanotide): Research Applications and Quality ..., https://wheretofindpeptides.com/research/pt-141-bremelanotide-research-applications-and-quality-assessment-1
42[PDF] The Discovery and Development of Bremelanotide (PT-141), https://www.benchchem.com/pdf/The_Discovery_and_Development_of_Bremelanotide_PT_141_A_Technical_Guide.pdf
81Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC2253185/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/
101PT-141 (Bremelanotide Acetate): Clinical Overview, Uses ... - eNavvi, https://enavvi.com/insights/pt-141-bremelanotide-for-sexual-dysfunction-clinical-guide-for-physicians
17Sermorelin - Wikipedia, https://en.wikipedia.org/wiki/Sermorelin
27Sermorelin, https://pubchem.ncbi.nlm.nih.gov/compound/Sermorelin
94Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth-hormone-releasing_hormone_receptor
103Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone_releasing_hormone_receptor
120Growth hormone–releasing hormone - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone%E2%80%93releasing_hormone